Command Medical Products Welcomes Mike Fillion as New CEO to Lead Growth

Command Medical Products Welcomes Mike Fillion as New CEO

Command Medical Products, a prominent player in the medical device and life sciences contract manufacturing sector, has announced the appointment of Mike Fillion as its next Chief Executive Officer. This transition takes effect on November 10, 2025, marking a new chapter in the company's illustrious history.

Mike Fillion steps into this critical role succeeding Jim Carnall, who has been at the helm for the past 16 years. Under Carnall's stewardship, Command Medical built a solid operational foundation, developed trusted partnerships with customers, and cultivated a reputation for manufacturing excellence in the medical device industry. As Carnall transitions into retirement, there are high expectations for Fillion to leverage his extensive background to guide the company into its next growth phase.

With over 30 years of experience in manufacturing and operations, Fillion is well-equipped to tackle the challenges ahead. He has cultivated a strong focus on precision metal products, medical devices, continuous improvement processes, and strategic business planning throughout his career. His most recent position as Chief Operating Officer at Conformis saw him manage operations across the United States and India, where he was responsible for approximately 250 employees across three sites in two countries.

Before that, Fillion held the title of Executive Vice President of Global Operations at Tecomet, a contract manufacturing company specializing in the medical device sector. During his tenure at Tecomet, he oversaw global operations that included 2,000 employees scattered across 17 manufacturing locations on three continents. His vast experience navigating complex manufacturing environments has equipped him with unique insights and skills that will be invaluable in his new role.

Jim Fitzgerald, Executive Chairman of Command's Board of Directors, expressed confidence in Fillion’s capabilities, stating, “Mike's proven leadership and deep understanding of global manufacturing make him the right leader to guide Command into its next stage of growth. His experience and success in complex environments will strengthen our ability to deliver value to customers and drive long-term growth.”

Command Medical Products, founded in 1987, is recognized for its commitment to high-quality contract manufacturing, focusing on single-use disposable medical devices. The company has steadily established itself as an industry leader, with a portfolio aimed at supporting OEMs and life sciences businesses.

Meanwhile, Argosy Healthcare Partners, the firm under which Command Medical operates, stands as a lower middle-market private equity firm dedicated to healthcare investments. AHP strategically partners with founder-owned healthcare businesses in the United States that gross between $1.0 to $3.0 million of EBITDA, seeking to execute control transactions. The firm's emphasis on preserving company culture and facilitating growth through active reinvestment aligns seamlessly with Command Medical’s ethos.

With Mike Fillion at the helm, Command Medical Products is poised to capitalize on its existing strengths while strategically positioning itself for the future. This leadership transition not only signifies a continuity of operational excellence but also heralds a commitment to innovation and sustained growth in the evolving healthcare landscape.

Those interested in learning more about Command Medical Products can visit the company’s official website at www.commandmedical.com and further insights into Argosy Healthcare Partners at www.argosyhp.com.